WallStreetZenWallStreetZen

NASDAQ: INNV
Innovage Holding Corp Stock Forecast, Predictions & Price Target

Analyst price target for INNV

Based on 5 analysts offering 12 month price targets for Innovage Holding Corp.
Min Forecast
$3.90-48.89%
Avg Forecast
$5.98-21.63%
Max Forecast
$8.00+4.85%

Should I buy or sell INNV stock?

Based on 5 analysts offering ratings for Innovage Holding Corp.
Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
4 analysts 80%
Sell
0 analysts 0%
Strong Sell
1 analysts 20%

Be the first to know when Wall Street analysts revise their INNV stock forecasts and price targets.

INNV stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Goldman Sachs
Bottom 13%
13
HoldMaintains$8.00+4.85%2022-11-23
Citigroup
Bottom 12%
12
HoldMaintains$8.00+4.85%2022-11-16
Barclays
Bottom 9%
9
HoldMaintains$5.00-34.47%2022-09-15
Baird
Bottom 9%
9
HoldDowngrades$5.00-34.47%2022-05-16
Piper Sandler
Bottom 5%
5
Strong SellMaintains$3.90-48.89%2022-05-11

1 of 1

Forecast return on equity

Is INNV forecast to generate an efficient return?
Company
N/A
Industry
-0.01%
Market
12.46%

Forecast return on assets

Is INNV forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.01%

INNV earnings per share forecast

What is INNV's earnings per share in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$0.06
Avg 2 year Forecast
$0.35
Avg 3 year Forecast
$0.53

INNV revenue forecast

What is INNV's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$725.4M+4.11%
Avg 2 year Forecast
$778.7M+11.75%
Avg 3 year Forecast
$1.4B+96.47%
INNV's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

INNV revenue growth forecast

How is INNV forecast to perform vs Medical Care Facilities companies and vs the US market?
Company
22.2%
Industry
9.93%
Market
9.35%
INNV's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
INNV's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

INNV vs Medical Care Facility Stocks

TickerPricePrice TargetUp/downsideConsensus
INNV$7.63$5.98-21.63%Hold
DCGO$9.95$11.00+10.55%Strong Buy
HCSG$13.08$14.38+9.90%Hold
NHC$57.35N/AN/A
USPH$95.41$113.33+18.79%Strong Buy

Innovage Holding Stock Forecast FAQ

Is Innovage Holding Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: INNV) stock is to Hold INNV stock.

Out of 5 analysts, 0 (0%) are recommending INNV as a Strong Buy, 0 (0%) are recommending INNV as a Buy, 4 (80%) are recommending INNV as a Hold, 0 (0%) are recommending INNV as a Sell, and 1 (20%) are recommending INNV as a Strong Sell.

If you're new to stock investing, here's how to buy Innovage Holding stock.

What is INNV's earnings growth forecast for 2023-2025?

(NASDAQ: INNV) Innovage Holding's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Care Facilities industry's average forecast earnings growth rate of 13.75%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 24.24%.

Innovage Holding's earnings in 2023 is -$27,280,000.On average, 2 Wall Street analysts forecast INNV's earnings for 2023 to be $8,134,200, with the lowest INNV earnings forecast at -$5,422,800, and the highest INNV earnings forecast at $20,335,501. On average, 1 Wall Street analyst forecast INNV's earnings for 2024 to be $47,449,503, with the lowest INNV earnings forecast at $47,449,503, and the highest INNV earnings forecast at $47,449,503.

In 2025, INNV is forecast to generate $71,852,104 in earnings, with the lowest earnings forecast at $71,852,104 and the highest earnings forecast at $71,852,104.

What is INNV's revenue growth forecast for 2023-2025?

(NASDAQ: INNV) Innovage Holding's forecast annual revenue growth rate of 22.2% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 9.93%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 9.35%.

Innovage Holding's revenue in 2023 is $696,787,000.On average, 2 Wall Street analysts forecast INNV's revenue for 2023 to be $98,347,228,753, with the lowest INNV revenue forecast at $98,152,685,792, and the highest INNV revenue forecast at $98,541,771,715. On average, 1 Wall Street analysts forecast INNV's revenue for 2024 to be $105,561,586,729, with the lowest INNV revenue forecast at $105,561,586,729, and the highest INNV revenue forecast at $105,561,586,729.

In 2025, INNV is forecast to generate $185,595,340,952 in revenue, with the lowest revenue forecast at $185,595,340,952 and the highest revenue forecast at $185,595,340,952.

What is INNV's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: INNV) forecast ROA is N/A, which is lower than the forecast US Medical Care Facilities industry average of -0.01%.

What is INNV's Price Target?

According to 5 Wall Street analysts that have issued a 1 year INNV price target, the average INNV price target is $5.98, with the highest INNV stock price forecast at $8.00 and the lowest INNV stock price forecast at $3.90.

On average, Wall Street analysts predict that Innovage Holding's share price could fall to $5.98 by Nov 23, 2023. The average Innovage Holding stock price prediction forecasts a potential downside of 21.63% from the current INNV share price of $7.63.

What is INNV's Earnings Per Share (EPS) forecast for 2023-2025?

(NASDAQ: INNV) Innovage Holding's current Earnings Per Share (EPS) is -$0.21. On average, analysts forecast that INNV's EPS will be $0.06 for 2023, with the lowest EPS forecast at -$0.04, and the highest EPS forecast at $0.15. On average, analysts forecast that INNV's EPS will be $0.35 for 2024, with the lowest EPS forecast at $0.35, and the highest EPS forecast at $0.35. In 2025, INNV's EPS is forecast to hit $0.53 (min: $0.53, max: $0.53).

What is INNV's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: INNV) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.